Chad M Robins
CEO, Chair at Adaptive Biotechnologies Corp (ADPT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $39.8M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 19SEC | ADPTAdaptive Biotechnologies Corp | Sell | 318,7992,183,043 held (−13%) | $25.08 | $8.0M | +5.6% |
| Aug 19SEC | ADPTAdaptive Biotechnologies Corp | Sell | 2,5252,180,518 held (−0%) | $25.57 | $65K | +3.6% |
| Aug 19SEC | ADPTAdaptive Biotechnologies Corp | Sell | 278,4722,180,722 held (−11%) | $24.48 | $6.8M | +8.2% |
| Aug 19SEC | ADPTAdaptive Biotechnologies Corp | Sell | 2042,180,518 held (−0%) | $25.14 | $5K | +5.4% |
| Apr 8SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 83,3322,217,781 held (−4%) | $14.41 | $1.2M | +83.8% |
| Apr 8SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 37,2632,180,518 held (−2%) | $15.19 | $566K | +74.4% |
| Mar 13SEC | ADPTAdaptive Biotechnologies Corp | Sell | 140,5672,630,713 held (−5%) | $13.17 | $1.9M | +101.1% |
| Mar 13SEC | ADPTAdaptive Biotechnologies Corp | Sell | 329,6002,301,113 held (−13%) | $13.17 | $4.3M | +101.1% |
| Mar 3SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 182,8912,276,354 held (−7%) | $15.99 | $2.9M | +65.7% |
| Mar 3SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 289,0241,987,330 held (−13%) | $15.82 | $4.6M | +67.4% |
| Mar 3SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 50,7031,936,627 held (−3%) | $15.49 | $785K | +71.0% |
| Mar 3SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 2,3801,934,247 held (−0%) | $16.15 | $38K | +64.0% |
| Feb 4SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 124,9982,459,245 held (−5%) | $18.44 | $2.3M | +43.7% |
| Jan 7SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 124,9982,584,243 held (−5%) | $15.59 | $1.9M | +69.9% |
| Dec 1SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 35,7362,834,239 held (−1%) | $19.68 | $703K | +34.6% |
| Dec 1SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 124,9982,709,241 held (−4%) | $18.94 | $2.4M | +39.9% |
| Nov 12SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 86,1612,873,088 held (−3%) | $14.73 | $1.3M | +79.8% |
| Nov 12SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 1,2372,871,851 held (−0%) | $14.57 | $18K | +81.8% |
| Nov 12SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 1,8672,869,975 held (−0%) | $15.00 | $28K | +76.6% |
- Sell
CEO, Chair Chad M Robins sold $1.2M of ADPT at $14.41 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, Chair Chad M Robins sold $566K of ADPT at $15.19 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, Chair Chad M Robins sold $2.9M of ADPT at $15.99 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, Chair Chad M Robins sold $4.6M of ADPT at $15.82 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, Chair Chad M Robins sold $785K of ADPT at $15.49 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, Chair Chad M Robins sold $38K of ADPT at $16.15 — pre-scheduled 10b5-1 plan sale.